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he U.S. EPA’s new Protections for Subjects in Human
Research rule, which came into force on 7 April 2006,
was born of a need to tighten the ethical guidelines controlling
nonmedical human experimentation. The rule was ostensibly
designed to offer people greater protection in pesticide toxicity
experiments. But just two weeks after its coming into force, a
coalition of labor and environmental interest groups filed suit
against the EPA, challenging the rule’s legality and ethics.
Against a backdrop of claims of industry influence, financial
interests, and bipartisan rhetoric, the Second Circuit Court of
Appeals in New York City must now determine whether this
rule safeguards Americans against unethical experimentation
or sells them out to big business.
The plaintiffs—the Natural Resources Defense Council
(NRDC), Pesticide Action Network North America, San
Francisco Bay Area Physicians for Social Responsibility, and
Northwest Treeplanters and Farmworkers United, Oregon’s
union of farm, nursery, and reforestation workers—filed their
suit on 23 February 2006. They claim the new rule does not
meet the demands of Congress to afford the fullest protection
to human subjects—especially pregnant women and chil-
dren—in pesticide experiments, and charge that the rule is
undercut by numerous loopholes that ultimately encourage,
rather than deter, human testing. 
“EPA is giving its official blessing for pesticide companies
to use pregnant women, infants, and children as lab rats in fla-
grant violation of [the EPA Appropriations Act of August
2005] cracking down on this repugnant practice,” said Erik
Olson, senior attorney for the NRDC, in a 23 January 2006
press release from that organization. “There is simply no legal
or moral justification for the agency to allow human testing of
these dangerous chemicals. None.”
The Need for a New Rule
The new rule expands on the existing Federal Policy for the
Protection of Human Subjects (or “Common Rule”), which
covers the ethics of medical trials and governs human
research sponsored or regulated by federal agencies. The
Common Rule largely reflects the aims of the Nuremberg
Code, a document drawn up after World War II providing
the basis for modern human experimentation ethics. But
according to Human Pesticide Experiments, a June 2005
report drawn up for Senator Barbara Boxer (D–CA) and
Representative Henry Waxman (D–CA), the Common Rule
offers insufficient protection against pesticide companies that
pay people to be intentionally exposed to their products. 
Why would a pesticide company even want to conduct
experiments on humans in the first place? One key reason can
be found in the provisions of the 1996 Food Quality
Protection Act, which was passed to provide greater protection
for vulnerable populations (such as children) against pesticide
exposures via food. The act applied a 10-fold safety factor to
permissible levels of pesticide residues in food to account for
children’s greater vulnerability. Under the act, pesticides could
be granted a lower safety factor “only if, on the basis of reliable
data . . . [the lower factor] will be safe for infants and children.”
According to a 2004 National Academy of Sciences report titled
Intentional Human Dosing Studies for EPA Regulatory Purposes:
Scientific and Ethical Issues, several pesticide manufacturers con-
ducted human dosing studies in pursuit of lower safety factors.
But human testing raises important ethical questions that
need to be answered. For example, although the subjects in
these pesticide dosing studies were supposed to have given
their consent to participate, was it ethical to have asked them
in the first place? Would the benefits of these studies outweigh
the risks to the subjects (as recommended by the 1964
Declaration of Helsinki on human medical experimentation),
or just help the bottom line of the companies involved? 
Given the dilemma surrounding human experimentation,
in 1998 the Clinton administration placed a moratorium on
the EPA reviewing human experiments for setting permitted
exposure levels. When the moratorium was lifted by the Bush
administration after a court found procedural errors in its
establishment, Congress reacted by way of the 2005 EPA
Appropriations Act, demanding that the agency draw up new
ethical guidelines governing itself and all third parties wishing
to submit results to the agency for regulatory purposes.
Championing this cause was Representative Hilda Solis
(D–CA), along with Boxer and Waxman, whose 2005 report
claimed that 22 human pesticide experiments submitted to the
EPA for possible use in regulatory decision making were in
violation of ethical and scientific standards, for reasons such as
failure to obtain fully informed consent, dismissal of adverse
outcomes, and the use of unethical liability waivers.
In obedience to Congress, the EPA drew up a proposed
rule, which evolved into the final rule published on 2 February
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During this time the EPA received thousands
of criticisms that it took into account for
preparing the final draft—a document that
ended up little to the liking of the litigating
coalition or indeed of the politicians who had
demanded it. 
The coalition members allege that the
rule’s wording—with what they perceive to
be inherent loopholes—now actually encour-
ages rather than prohibits human experimen-
tation, and suggest that pesticide companies
could take advantage of this to further their
interests. “EPA’s rule allows pesticide compa-
nies to use intentional tests on humans to
justify weaker restrictions on pesticides,” said
Margaret Reeves, a senior scientist and pro-
gram coordinator with Pesticide Action
Network North America, in a press release
from that group announcing the filing of the
lawsuit. In the same press release, Robert
Gould, president of  San Francisco Bay Area
Physicians for Social Responsibility, was
quoted as saying, “Pesticide companies
should not be allowed to take advantage of
vulnerable populations by enticing people to
serve as human laboratory rats.”
In a press release issued by his office the
same day, Waxman commented: “Unethical
human pesticide experiments must be
stopped. It is morally wrong to encourage
chemical companies to dose humans with
pesticides in order to argue for weaker public
health standards.”
Question of Intent
One of the major intentions for the new
rule—and now a major bone of con-
tention—was that it ban the experimental
use of pregnant women and children.
Indeed, the EPA insists the rule does just
that. “This rule provides far-reaching pro-
tections for all Americans and absolute
protections for children and expectant
mothers,” explains senior policy advisor
William Jordan of the EPA Office of
Pesticide Programs. “It categorically inhibits
EPA or any researcher from using [such
subjects] in intentional dosing studies. The
rule further extends those protections by
banning any researcher for pesticides from
using pregnant women or children as partic-
ipants in any intentional dosing study
intended for submission to EPA.” 
Jordan says the rule also prohibits the
EPA from relying on any intentional pesti-
cide dosing study involving pregnant women
or children regardless of the intent of those
conducting the study or the country where
the study was conducted. Finally, he says, the
rule directs the EPA to waive that prohibition
“only if the agency were to become aware of
information that would indicate the need for
stricter regulatory controls for a pesticide.”
The coalition, however, points to what it
considers to be several exceptions to the rule.
They note that while Americans may be
offered some protection from intentional dos-
ing studies, the rule does nothing to prevent
U.S. pesticide companies from performing
experiments on nationals in other countries. 
The term “intended for submission to
the EPA” worries them too. “The wording of
the rule means you are not allowed to do a
study on pregnant women or children that
you admit was intended from the beginning
for submission to the EPA,” explains Olson.
“If that was not your original idea—or if you
say it wasn’t—then you apparently could do
those experiments. A second scenario could
be where a company performs a study on
infants or pregnant women and submits it to
a state or, say, a European country, saying
that it does not intend to submit it to the
EPA. We have plenty of experience to show
that decisions made by other bodies are very
influential on the EPA. [So], you can avoid
the EPA rule and still get the result you
want.” In addition, pesticide studies on preg-
nant women and children submitted under
clean water, drinking water, clean air, haz-
ardous waste, or other laws are not covered
by the new rule’s restrictions, Olson explains.
Jordan rejoins that the rule does not, in
fact, permit a registrant to claim at the outset
of a study that they have no intent to submit
a human pesticide study and then later sub-
mit that study. “If the agency were ever to
receive such a study done in this deceptive
fashion,” he insists, “the rule prevents EPA
from using it.”
Children’s Consent
Another major area of contention is consent.
In the proposed rule, section 26.408 of the
text clearly stated that “if the [institutional
review board] determines a research protocol
is designed for conditions or for a subject
population for which parental or guardian
permission is not a reasonable requirement to
protect the subjects (for example, neglected
or abused children), it may waive the consent
requirements in subpart A of this part and
paragraph (b) of this section.” Subpart A
refers to the requirement that a child must
assent to be included in an experiment
(although this was apparently not necessary
“if the capability of some or all of the chil-
dren is so limited that they cannot reasonably
be consulted”), while paragraph (b) refers to
soliciting permission from parents or
guardians. Many critics believed this waiver
suggested that abused or mentally impaired
children could be freely used in commercial
pesticide experiments.
In comments published with the final
rule, the EPA says such a sinister reading is
incorrect: “Many commenters misinterpreted
EPA’s proposed language. Contrary to pub-
lic comments, none of the alleged ‘loop-
holes’ ever existed, because the prohibition
in proposed Sec. 26.420 stated ‘Notwith-
standing any other provision of this part,
under no circumstances shall EPA or a per-
son when covered by Sec. 26.101(j) conduct
or support research involving intentional
dosing of any child.’”
According to the EPA, the words “Not-
withstanding any other provision of this part”
meant that the provisions in proposed Section
26.420 overrode all other provisions of the
entire regulation, including those in 26.408.
So even though the latter section would have
appeared to give the EPA the authority to
waive certain requirements, it did not, the
agency claims, authorize any departure from
the ban declared in Section 26.420. In
Jordan’s words, no child is going to be used in
intentional dosing studies—period. 
“But if this is what it means, why doesn’t
it simply say that?” asks Olson. “It sure
appears that if there is no ‘intent to submit’ to
EPA then you could use such children.” 
The wording in the final rule is scarcely
different from that in the original version. The
proposed Section 26.408, now named Section
26.406, remains virtually intact, while the
promise in the proposed Section 26.420 has
been consolidated into a blanket statement in
the final Section 26.203 that “under no cir-
cumstances shall EPA conduct or support
research involving intentional exposure of any
human subject who is a pregnant woman (and
therefore her fetus) or child.”
Other concerns voiced by the coalition
include claims that the ethics review board
established by the new rule is powerless to
prevent experiments it deems unethical (its
role is merely advisory), that nowhere is any
sanctioning power mentioned, and that a
clause in the text requires that any studies
presented need only “substantially” comply
with the rule—a quantity of compliance that
is never defined. 
Given the EPA’s funding of the now-
cancelled CHEERS study (which would
have paid parents to let EPA and industry
scientists observe the effects on their children
of spraying their homes with pesticide, but
which was abandoned by the agency in the
face of overwhelming criticism; the EPA
declined to comment to EHP on the study),
the fundamental question arises as to
whether the agency should be allowed to
write its own rules. It is now the job of the
courts to decide whether the EPA has done a
good job. Briefings will begin 5 June 2006,
but a ruling could take a year or more to
come through. In the meantime, the new
rule is in force.
Adrian Burton
A 362 VOLUME 114 | NUMBER 6 | June 2006 • Environmental Health Perspectives
Spheres of Influence | Human Experimentation
114N6 Spheres of Influence RPP  5/12/06  4:49 PM  Page A 362BREASTFEED FOR SIX MONTHS. HELP REDUCE YOUR CHILD’S RISK FOR EAR INFECTIONS.
U.S. Department of Health and Human Services
Recent studies show you can lower your child’s risk of ear infections by breastfeeding exclusively for six
months. Call 800-994-WOMAN or visit www.4woman.gov to learn more. Or talk to your healthcare provider
Babies were born to be breastfed.
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